Summary

Market Overview
The global tourniquet market size was valued at US$ 390.85 million in 2021 and is estimated to reach US$ 678.21 million by 2029, growing at a CAGR of 7.9% during the forecast period (2022-2029).
Tourniquet use is a familiar approach in orthopedic and plastic surgeries. They are compressive instruments that block blood flow to the extremes to produce a bloodless surgical field and reduce perioperative blood loss. They are also employed for intravenous regional anesthesia (Bier's block) to control the central spread of local anesthetics.
Market Dynamics
The growing number of orthopedic surgeries, plastic surgeries and the increasing incidents of road accident trauma drive the tourniquet Market growth during the forecast period.
Tourniquets are regularly and safely utilized in extremities surgeries throughout the globe. Thus, the increasing number of orthopedic and plastic surgeries boosts global tourniquet market growth. For instance, according to the European Union 2020 statistics, hip replacements were performed about 294 times per 100 000 residents in Germany in 2020 and between 250 and 269 times per 100 000 inhabitants in Finland, Austria, and the Netherlands (2019 data) and Denmark; these were the most elevated commonnesses among the EU Member States for which data are known, knee replacements varied more between the EU Member States than did hip replacements. Furthermore, except for Malta, total knee replacements were less common than hip replacements. For instance, in 2020, more than 200 knee replacements per 100 000 inhabitants were performed in Finland and Germany.
In addition, according to the American Joint Replacement Registry 2021, over 2.4 million hip and knee surgeries from over 1150 institutions that presented data took place in 2021, representing an 18.3% upsurge in total procedural volume compared with that in 2020. Likewise, according to the American Society of Plastic Surgeons, around 15.6 million cosmetic procedures comprised 2.3 million cosmetic surgical procedures and 13.2 million cosmetic minimally-invasive procedures, and about 6.8 million reconstructive procedures were performed in 2020. Besides, the increasing number of road accidents contributes to the growth of the global tourniquet Market. For example, according to statistics from the world health organization, roughly 1.3 million people die yearly from road casualty emergencies. Almost 20-50 million individuals suffer from non-fatal injuries. Moreover, the CDC has supplied statistics of non-fatal injuries needing surgery in 2020, with approximately 2,885,545 ambulatory cases. From the data mentioned above, the rising number of orthopedic surgeries, plastic surgeries and incidents of road accidents worldwide is pushing the global tourniquet market growth.
The incidences of tourniquet injuries will restrain the global tourniquet market growth.
However, the implication of a tourniquet in surgery is the threat of clinical skin, muscle, blood vessels, connective tissue, and nerve damage because of numbness, paresis, or paralysis with muscle atrophy. Among these, hypoxia and acidosis primarily induce tissue ischemia and muscle damage. Furthermore, after releasing the tourniquet, perfusion leads to a physiological elevation in blood pressure, lowered body temperature, and oxygen stress, which is connected to the reentry toxic metabolites back into the systemic circulation. Such complications associated with tourniquet use are restraining the global market growth in the forecast period.
COVID-19 Impact.
During the COVID-19 pandemic, the constraint on socializing and social assemblages lessened the numeral of road traffic casualties, sports harms, and other medical ailments demanding surgical intervention, forcing a decline in the market growth globally. For example, according to the International Society of Aesthetic Plastic Surgery, plastic surgery procedures dropped during the pandemic. Approximately 10.9% and around 78% of surgeons experienced temporary practice closure. Furthermore, according to the national health institute, orthopedic surgery was down by about 23% during the first pandemic year. Among which orthopedic surgeries, knee arthroplasty had the utmost influence. It was down by almost 64%, pursued by hip arthroplasty and knee ligament reconstruction by about 41% and 44%, respectively, lessening the need for a tourniquet market. These statistics show that the tourniquet market was negatively impacted by the covid-19 pandemic globally.
Segment Analysis
Tourniquet systems are expected to dominate the market throughout the forecast period (2022-2029).
The increasing access to specialty care products, pathological products, clinical examination, and diagnosis at a single premise is best possible in hospitals, indicating an exponential segment growth. Hospitals are the major end-user facilities for tourniquets. Moreover, the increasing numeral of sports-related injuries and road casualties raises the number of orthopedic cases, thereby driving the need for hospital-related cases. According to the National Safety Council (NSC), over 55.4 million injuries were experienced in the United States, a 15.7% increase from 2019 to 2020. The Bureau of Labor Statistics (BLS) reports that private industry employers registered over 2.7 million nonfatal workplace injuries and illnesses in 2020. The preventable injuries in the home in 2020 were about 31,800,000 means that one person in 10 in the U.S. encountered a medically consulted injury. Likewise, bicycling accounted for about 426,000 injuries in 2020. According to the National Center for Health Statistics, part of the Centers for Disease Control and Prevention, hospital emergency rooms across the country receive over 145.6 million patients annually.
Old people are more susceptible to orthopedic disorders. According to the World Population Aging globally, there were 727 million persons aged 65 years or over in 2020. Since women live longer than men, they comprise the majority of older persons, especially at advanced ages. This rise in life expectancies and age-related comorbidities results in the growth of geriatric orthopedic surgical procedures. Additionally, the central government offers partial or complete coverage for in-home services in most developed and developing nations. In the U.S., Medicare reimbursements are highly favorable in providing value-based healthcare for improved patient outcomes at a low cost. Thus, from the mentioned data, it is estimated that the hospital end user will dominate the global tourniquet market throughout the forecast period.
Geographical Analysis
The North American region holds the largest global Tourniquet market share.
North American tourniquets market will grow at high CAGR throughout the forecast period (2022-2029). According to the International Society of Aesthetic Plastic Surgery, the U.S. had an immense number of surgeons, with over 7,000 plastic surgeons in 2020, conducted across 3,182,815 non-surgical procedures and approximately 1,485,116 Surgical practices. Again, according to the same survey, the total number of operations executed in Mexico was over 860,718 in 2020. Likewise, from the data obtained by the U.S. Department of transportation`s fatality analysis reporting system, approximately 35,766 fatal vehicle crashes occurred in the U.S. in 2020, inducing roughly 38,824 deaths.
Additionally, there are presently nearly 18,380 orthopedic surgeons in America practicing, indicating that North America maintains a major market share. Another reason North America owns a significant market share is the risen prevalence of obesity. For example, according to the National data from the 2017-2020 National Health and Nutrition Examination Survey, more than 41.9% of adults are obese. Therefore, from about mentioned data, it is predicted that North America will dominate the global Tourniquet Market during the forecast period (2022-2029).
Competitive Landscape
The tourniquet market is moderately competitive due to the presence of key local and global players. Some key players are Zimmer Biomet, Stryker, ATMOS MedizinTechnik GmbH & Co. KG, VBM, DDM, Anetic Aid, HPM, Huifeng Medical, DS MAREF, and Bohua Medical. These key players hold the major share of the market through innovations, product launches, collaborations, acquisitions, and alliances. For instance, in May 2021, ATMOS MedizinTechnik GmbH & Co. KG acquired the tourniquets device portfolio of Ulrich medical.
Zimmer Biomet
Overview:
Zimmer Biomet was in 1927 and has operations in more than 25 countries around the world and more than 100 countries to sell their product with a vast portfolio. Also, it is a leading company focusing on alleviating pain and improving the quality of life for people around the world.
Product Portfolio:
Zimmer Biomet’s tourniquet product portfolio has A.T.S. 5000 Tourniquet Systems: The A.T.S. 5000 combines Personalized Pressure Technology with the new customizable user choosing to deliver a personalized experience for patients and healthcare professionals without disrupting workflow.
The global tourniquet market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

ページTOPに戻る

Table of Contents